Organization

The Second Affiliated Hospital of Shandong First Medical University, Tai’an, China

1 abstract

Abstract
Efficacy and safety of SOX regimen combined with inetetamab as first-line treatment for HER2-positive advanced gastric cancer.
Org: The Second Affiliated Hospital of Shandong First Medical University, Tai’an, China,